Works matching IS 2076-393X AND VI 11 AND IP 3 AND DT 2023
Results: 221
COVID-19 Vaccine Hesitancy in China: An Analysis of Reasons through Mixed Methods.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 712, doi. 10.3390/vaccines11030712
- By:
- Publication type:
- Article
Deep Mutational Scanning to Predict Escape from Bebtelovimab in SARS-CoV-2 Omicron Subvariants.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 711, doi. 10.3390/vaccines11030711
- By:
- Publication type:
- Article
An In Silico Deep Learning Approach to Multi-Epitope Vaccine Design: A Hepatitis E Virus Case Study.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 710, doi. 10.3390/vaccines11030710
- By:
- Publication type:
- Article
Modeling Behavior and Vaccine Hesitancy Using Twitter-Derived US Population Sentiment during the COVID-19 Pandemic to Predict Daily Vaccination Inoculations.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 709, doi. 10.3390/vaccines11030709
- By:
- Publication type:
- Article
Vaccine Interaction and Protection against Virulent Avian Metapneumovirus (aMPV) Challenge after Combined Administration of Newcastle Disease and aMPV Live Vaccines to Day-Old Turkeys.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 708, doi. 10.3390/vaccines11030708
- By:
- Publication type:
- Article
Perspectives of Next-Generation Live-Attenuated Rift Valley Fever Vaccines for Animal and Human Use.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 707, doi. 10.3390/vaccines11030707
- By:
- Publication type:
- Article
Assessing COVID-19 Vaccine Booster Hesitancy Using the Modified 5C Scale in Zhejiang Province, China: A Cross-Sectional Study.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 706, doi. 10.3390/vaccines11030706
- By:
- Publication type:
- Article
Surviving COVID-19: Biopsychosocial Impacts, Death Anxiety, and Coping Strategies.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 705, doi. 10.3390/vaccines11030705
- By:
- Publication type:
- Article
Follow-Up of Side Effects throughout the Entire Course of Coronavirus Vaccination.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 704, doi. 10.3390/vaccines11030704
- By:
- Publication type:
- Article
Adherence to Vaccines in Adult Patients with Immune-Mediated Inflammatory Diseases: A Two-Year Prospective Portuguese Cohort Study.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 703, doi. 10.3390/vaccines11030703
- By:
- Publication type:
- Article
Genetic Diversity and Evolutionary Kinetics of Influenza A Virus H3N2 Subtypes Circulating in Riyadh, Saudi Arabia.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 702, doi. 10.3390/vaccines11030702
- By:
- Publication type:
- Article
Heterologous Vector—mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector—Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 701, doi. 10.3390/vaccines11030701
- By:
- Publication type:
- Article
Evaluation of the Approach towards Vaccination against COVID-19 among the Polish Population—In Relation to Sociodemographic Factors and Physical and Mental Health.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 700, doi. 10.3390/vaccines11030700
- By:
- Publication type:
- Article
COVID-19 Disease in Under-5 Children: Current Status and Strategies for Prevention including Vaccination.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 693, doi. 10.3390/vaccines11030693
- By:
- Publication type:
- Article
Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 699, doi. 10.3390/vaccines11030699
- By:
- Publication type:
- Article
The Correlation of Papanicolaou Smears and Clinical Features to Identify the Common Risk Factors for Cervical Cancer: A Retrospective and Descriptive Study from a Tertiary Care Hospital in Trinidad.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 697, doi. 10.3390/vaccines11030697
- By:
- Publication type:
- Article
Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 696, doi. 10.3390/vaccines11030696
- By:
- Publication type:
- Article
The Integrated Consideration of Vaccine Platforms, Adjuvants, and Delivery Routes for Successful Vaccine Development.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 695, doi. 10.3390/vaccines11030695
- By:
- Publication type:
- Article
An Epidemiological Study of Brucellosis in Different Animal Species from the Al-Qassim Region, Saudi Arabia.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 694, doi. 10.3390/vaccines11030694
- By:
- Publication type:
- Article
Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 698, doi. 10.3390/vaccines11030698
- By:
- Publication type:
- Article
Longitudinal Profiles of Anti-Platelet Factor 4 Antibodies in Thai People Who Received ChAdOx1 nCoV-19 Vaccination.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 692, doi. 10.3390/vaccines11030692
- By:
- Publication type:
- Article
Patients' Post-/Long-COVID Symptoms, Vaccination and Functional Status—Findings from a State-Wide Online Screening Study.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 691, doi. 10.3390/vaccines11030691
- By:
- Publication type:
- Article
The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 690, doi. 10.3390/vaccines11030690
- By:
- Publication type:
- Article
Uncovering the Drivers of Childhood Immunization Inequality with Caregivers, Community Members and Health System Stakeholders: Results from a Human-Centered Design Study in DRC, Mozambique and Nigeria.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 689, doi. 10.3390/vaccines11030689
- By:
- Publication type:
- Article
Retrospective Analysis of Vaccinated and Unvaccinated COVID-19 Patients Treated with Monoclonal Antibodies (mAb) and Their Emergent Needs (RAVEN).
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 688, doi. 10.3390/vaccines11030688
- By:
- Publication type:
- Article
Exosomes as Rheumatoid Arthritis Diagnostic Biomarkers and Therapeutic Agents.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 687, doi. 10.3390/vaccines11030687
- By:
- Publication type:
- Article
Dutch Healthcare Professionals' Opinion on the Allocation of Responsibilities concerning Prescribing and Administering Medically Indicated Vaccines to Immunocompromised Patients.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 686, doi. 10.3390/vaccines11030686
- By:
- Publication type:
- Article
Immunization Gender Inequity in Pakistan: An Analysis of 6.2 Million Children Born from 2019 to 2022 and Enrolled in the Sindh Electronic Immunization Registry.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 685, doi. 10.3390/vaccines11030685
- By:
- Publication type:
- Article
Immune Response to CoronaVac and Its Safety in Patients with Type 2 Diabetes Compared with Healthcare Workers.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 684, doi. 10.3390/vaccines11030684
- By:
- Publication type:
- Article
COVID-19 Vaccine Acceptance among University Students and Lecturers in Different Provinces of Indonesia: A Cross-Sectional Study.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 683, doi. 10.3390/vaccines11030683
- By:
- Publication type:
- Article
SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 682, doi. 10.3390/vaccines11030682
- By:
- Publication type:
- Article
Studying T Cell Responses to Hepatotropic Viruses in the Liver Microenvironment.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 681, doi. 10.3390/vaccines11030681
- By:
- Publication type:
- Article
Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 680, doi. 10.3390/vaccines11030680
- By:
- Publication type:
- Article
End-Stage Kidney Disease Resulting from Atypical Hemolytic Uremic Syndrome after Receiving AstraZeneca SARS-CoV-2 Vaccine: A Case Report.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 679, doi. 10.3390/vaccines11030679
- By:
- Publication type:
- Article
Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 678, doi. 10.3390/vaccines11030678
- By:
- Publication type:
- Article
Is Pre-Exposure Prophylaxis a Cost-Effective Intervention to Avert Rabies Deaths among School-Aged Children in India? Comment on Royal et al. A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India. Vaccines 2023, 11 , 88
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 677, doi. 10.3390/vaccines11030677
- By:
- Publication type:
- Article
Safety Profile of Homologous and Heterologous Booster COVID-19 Vaccines in Physicians in Quito-Ecuador: A Cross-Sectional Study.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 676, doi. 10.3390/vaccines11030676
- By:
- Publication type:
- Article
The Course of COVID-19 among Unvaccinated Patients—Data from the National Hospital in Warsaw, Poland.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 675, doi. 10.3390/vaccines11030675
- By:
- Publication type:
- Article
Candida parapsilosis Cell Wall Proteome Characterization and Effectiveness against Hematogenously Disseminated Candidiasis in a Murine Model.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 674, doi. 10.3390/vaccines11030674
- By:
- Publication type:
- Article
Intraduodenal Delivery of Exosome-Loaded SARS-CoV-2 RBD mRNA Induces a Neutralizing Antibody Response in Mice.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 673, doi. 10.3390/vaccines11030673
- By:
- Publication type:
- Article
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 672, doi. 10.3390/vaccines11030672
- By:
- Publication type:
- Article
Structural and Phylogenetic Analysis of CXCR4 Protein Reveals New Insights into Its Role in Emerging and Re-Emerging Diseases in Mammals.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 671, doi. 10.3390/vaccines11030671
- By:
- Publication type:
- Article
BMI-Associated Anti-Apolipoprotein A-1 Positivity in Healthy Adults after mRNA-Vaccination against COVID-19.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 670, doi. 10.3390/vaccines11030670
- By:
- Publication type:
- Article
Using an Aluminum Hydroxide–Chitosan Matrix Increased the Vaccine Potential and Immune Response of Mice against Multi-Drug-Resistant Acinetobacter baumannii.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 669, doi. 10.3390/vaccines11030669
- By:
- Publication type:
- Article
Deep Structural Analysis of Myriads of Omicron Sub-Variants Revealed Hotspot for Vaccine Escape Immunity.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 668, doi. 10.3390/vaccines11030668
- By:
- Publication type:
- Article
The Impact of COVID-19 on Pediatric Malignancy Diagnosis and Treatment: Never the Same but Lessons Learned.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 667, doi. 10.3390/vaccines11030667
- By:
- Publication type:
- Article
CVAPPS: A Cross-Sectional Study of SARS-CoV-2 Vaccine Acceptance, Perceptions, and Post-Vaccination Side Effects among Rheumatic Disease Patients in Kuwait.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 666, doi. 10.3390/vaccines11030666
- By:
- Publication type:
- Article
New-Onset Arthritis Following COVID-19 Vaccination: A Systematic Review of Case Reports.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 665, doi. 10.3390/vaccines11030665
- By:
- Publication type:
- Article
Establishment and Application of Indirect ELISAs for Detecting Antibodies against Goose Astrovirus Genotype 1 and 2.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 664, doi. 10.3390/vaccines11030664
- By:
- Publication type:
- Article
Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children?
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 663, doi. 10.3390/vaccines11030663
- By:
- Publication type:
- Article